Caixin
Caixin Global – Latest China News & Headlines

Home >

ABOUT US

CX Tech is Caixin Global's real-time tech news portal, featuring 24-hour news, short-form analysis, and roundups from business and tech media in China.

TRENDING
WeWork Putting the Brakes on China Push: Report
Tencent-Backed E-Book Platform Partners With Disney for ‘Star Wars’ Project
Tesla’s China Plant Is Hooked Up to State Grid Power Supply
LATEST
Tencent-Backed E-Book Platform Partners With Disney for ‘Star Wars’ Project
iQiyi Looks to AI to Force-Feed Ads to Viewers
Popular Walking App Accused of Financial Fraud
WeWork Putting the Brakes on China Push: Report
‘No New Progress’ on Zotye Joint-Venture With Ford
Qutoutiao’s Online Literature Unit Gets $100 Million Windfall
NBA’s China Crisis Has Already Caused ‘Substantial’ Losses, Commissioner Says
Northern China Aims to Curb Toxic Air Pollution by 4% This Winter
China’s Economic Growth Dips to New Nearly Three-Decade Low
Tesla’s China Plant Is Hooked Up to State Grid Power Supply
Didi Pushes Further Into Latin America With Eye on Costa Rica
Homeowners Demand Refunds After Developer Cuts Prices
Controversial WeChat Public Account Operator Eyes High-Tech Board IPO
Burgeoning Online Marketplace in Crisis After Luring New Shoppers With Merchants’ Money
Huawei Posts Strong Revenue Growth Despite U.S. Export Ban
Ant Financial Seeks Loan of as Much as $3.5 Billion at Lower Rate
China Freezes Some Social Media, Mobile Payment Accounts in Myanmar Cross-Border Fraud Crackdown
Popular Translation App Youdao Downsizes New York IPO
Popular Alibaba-Backed Social E-Commerce App Returns After Months-Long Absence
Cheap-Phone Maker Realme Eyes Upscale Turn With Pricey New Handset
New Funding Values Chinese Artificial-Heart Maker at 1 Billion Yuan

By Wang Luyao and Tang Ziyi / Jun 24, 2019 12:55 PM / Business & Tech

People attend a medical-device fair in Kunming, Yunnan province, on Oct. 30, 2017. Photo: VCG

People attend a medical-device fair in Kunming, Yunnan province, on Oct. 30, 2017. Photo: VCG

Chinese artificial-heart maker Suzhou Tongxin Medical Equipment has received a transfusion of funding that values the company at around 1 billion yuan ($145 million).

The medical-device company received 102 million yuan from larger industry peer Blue Sail Medical, in exchange for a 10.16% stake in Tongxin, according to a recent statement from Blue Sail.

Tongxin makes magnetically-suspended artificial blood pumps which are designed to replace the human heart. They are undergoing clinical trials in China after being fast-tracked through the approval process by the National Medical Products Administration, state-run Xinhua News Agency reported

According to Blue Sail, the device has already been successfully trialed on four human patients.

The company is now applying for clinical trial approval from the U.S. Food and Drug Administration.

The Chinese government has ambitious aims for high-end medical device sector. According to the "Made in China 2025" manufacturing plan, China aims to increase the domestically produced share of sophisticated medical devices such as pacemakers and implants in Chinese hospitals to 50% by 2020, and to 70% by 2025.

Related: In Depth: Domestic Medical-Device Startups Struggling To Cut Through

Share this article
Open WeChat and scan the QR code